Fundraising Fox
/People
Sign in

Gino Santini

Board director at Alzheon

United States

Find your path to Gino

9 people in our graph share verified history with Gino — schools, employers, funds. One of them is your warm intro.

Martin Tolar, MD, PhDunlockedGino: together at Alzheon
×8Gino: together at Alzheon

About

Gino Santini serves as Chair of the Board of Directors at Lakefront Biotherapeutics and holds board and advisory roles with public and private companies, in addition to providing financing and business consulting services to investment, pharmaceutical, and biotech firms. He spent 28 years at Eli Lilly before retiring in December 2010, holding executive positions including President of US Operations and Senior Vice President of Corporate Strategy and Business Development. His career has spanned operational and strategic roles across three continents and multiple areas of the pharmaceutical value chain.

Board director at Alzheon

Intro paths

→

In turn, Gino can intro founders to Alzheon's investors below.

Alzheon's investors · 1

ARCH Venture PartnersChicago · $50K – $250M checks · since 2014

Co-founders at Alzheon

MTMartin Tolar, M.D., Ph.D.
Martin Tolar, M.D., Ph.D.President and Chief Executive Officer
MTMartin Tolar
Martin TolarExecutive Officer, Director
MTMartin Tolar, MD, PhD
Martin Tolar, MD, PhDFounder

Experience

  1. Lakefront Biotherapeutics (former Galapagos)Chair of the Board of Directorscurrent2026 — presentMechelen
  2. Compass PathwaysChairman of the Boardcurrent2024 — presentLondon Area, United Kingdom
  3. Alzheon, Inc.Board Membercurrent2024 — present
  4. AlfasigmaBoard Membercurrent2024 — present
  5. Collegium PharmaceuticalChairman of the Boardcurrent2012 — presentCanton, MA
  6. Intercept PharmaceuticalsBoard Member2015 — 2023
  7. Horizon PharmaBoard member2012 — 2023
  8. Allena PharmaceuticalsBoard Member2012 — 2022
  9. Intarcia TherapeuticsBoard Member2013 — 2020Greater Boston Area
  10. AMAG PharmaceuticalsChairman of the Board2012 — 2020
  11. Vitae PharmaceuticalsBoard Member2014 — 2016
  12. Sorin GroupBoard Member2012 — 2015Milano, Italy
  13. Finanziaria Saccarifera Italo IbericaBoard Member2013 — 2014Cesena, Italy
  14. Eli Lilly and CompanySenior VP Corporate Strategy & Business Development2008 — 2010Indianapolis
  15. Eli Lilly and CompanySenior VP Corporate Strategy and Policy2004 — 2007Indianapolis, Indiana Area
  16. Eli Lilly and CompanyPresident US Operations1999 — 2004Indianapolis, Indiana Area
  17. Eli Lilly and CompanyPresident - Women"s Health1997 — 1999Indianapolis, Indiana Area
  18. Eli Lilly and CompanyVice President - Corporate Strategy and Business Development1995 — 1997Indianapolis, Indiana Area
  19. Eli Lilly and CompanyArea Director - Latin America1994 — 1995Indianapolis, Indiana Area
  20. Eli Lilly and CompanyGeneral Manager - Mexico1991 — 1994Mexico City Area, Mexico
  21. Eli Lilly and CompanyPharmaceutical Director1990 — 1991Brussels Area, Belgium

Frequently asked questions

Who is Gino Santini?
Gino Santini serves as Chair of the Board of Directors at Lakefront Biotherapeutics and holds board and advisory roles with public and private companies, in addition to providing financing and business consulting services to investment, pharmaceutical, and biotech firms. He spent 28 years at Eli Lilly before retiring in December 2010, holding executive positions including President of US Operations and Senior Vice President of Corporate Strategy and Business Development. His career has spanned operational and strategic roles across three continents and multiple areas of the pharmaceutical value chain.
Where does Gino Santini work?
Gino Santini is Board director at Alzheon.
Where did Gino Santini go to school?
Gino Santini studied at University of Rochester (MBA, Finance, Economics); Alma Mater Studiorum – Università di Bologna (Laurea in Ingegneria Meccanica).

Same school

Shared employers